SCHEMBL2552259

SCHEMBL2552259

CC(C)(C)OC(=O)NCCc1nc(CO)co1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.50
NPSR1 Q6W5P4 1/20 0.50
ALDH1A1 P00352 5/20 0.45
TDP1 Q9NUW8 2/20 0.44
MAPT P10636 1/20 0.44
LMNA P02545 3/20 0.43
HPGD P15428 2/20 0.43
GAA P10253 1/20 0.43
TSHR P16473 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PKM P14618 1/20 0.42
POLB P06746 1/20 0.41
NQO2 P16083 1/20 0.41
GFER P55789 1/20 0.41
KDM4E B2RXH2 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2557942 0.88 HTT (0.49) HTTNPSR1ALDH1A1TDP1MAPT
SCHEMBL3798888 0.86 KDM4A (0.40) HTTNPSR1TDP1LMNAGFER
SCHEMBL2552253 0.84 HTT (0.52) HTTNPSR1ALDH1A1TDP1MAPT
SCHEMBL18764998 0.82 HTT (0.50) HTTNPSR1ALDH1A1TDP1MAPT
SCHEMBL2554277 0.81 HTT (0.49) HTTNPSR1ALDH1A1TDP1MAPT
SCHEMBL24921899 0.76 CA12 (0.48) HTTALDH1A1TDP1LMNAGAA
SCHEMBL10178236 0.75 HTT (0.54) HTTNPSR1ALDH1A1TDP1MAPT
SCHEMBL1732261 0.75 LCK (0.37) TDP1GAAMEN1KMT2A
SCHEMBL6464868 0.75 KDM4A (0.40) HTTNPSR1TDP1MAPTLMNA
SCHEMBL22730736 0.74 HTT (0.56) HTTNPSR1ALDH1A1TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2763990-A1 PYRROLOPYRAZINE KINASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2014-08-13 EP disclosed
WO-2013030138-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2013-03-07 WO disclosed
WO-2011130383-A1 COMPOUNDS CONTAINING FUSED RINGS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF COMENTIS, INC. (US) 2011-10-20 WO disclosed
EP-2205596-A1 (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING COMENTIS, INC. (US) 2010-07-14 EP disclosed
EP-2178837-A2 ISOPHTHALAMIDE DERIVATIVES INHIBITING BETA-SECRETASE ACTIVITY COMENTIS, INC. (US) 2010-04-28 EP disclosed
WO-2009042694-A1 (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING COMENTIS, INC. (US) 2009-04-02 WO disclosed
WO-2009015369-A2 COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF COMENTIS, INC. (US) 2009-01-29 WO disclosed